Conservative UK Police Commissioners Call for Increasing Penalties for Cannabis

10/03/2022

by

Conservative police commissioners in the United Kingdom are calling for cannabis to be reclassified from a Class B to Class A drug, BBC News reports. If approved, the change would put cannabis in the same category as heroin and cocaine and mean harsher penalties for possession and potential life sentences in prison for dealers and producers.

The Home Office told the BBC that there are no plans to back the reclassification. 

“There are currently no plans to reclassify cannabis, which is controlled as a Class B drug in the UK on the basis of clear medical and scientific evidence of its harms.” — Home Office spokesperson to the BBC 

David Sidwick, the Police and Crime Commissioner for Dorset, told the BBC that cannabis was “driving harm” in communities. 

“We’re seeing it because it’s a gateway drug,” Sidwick said. “If you look at the young people in treatment, the number one drug they are in treatment for is cannabis.”

Peter Reynolds, the President of CLEAR, which opposes cannabis prohibition, called the proposal “completely crazy.” 

“The idea of doing more of the same as the past 50 years, which has quite obviously dramatically failed, is ridiculous,” Reynolds told the BBC. “The only people who want this are ignorant politicians and the people who sell illegal drugs, I’m crystal clear about that.” 

Under UK drug laws, penalties for possession of a Class A drug include an unlimited fine and up to seven years in prison, while suppliers and producers can be sentenced to life. 

Sentences for Class B drugs are up to five years for possession and up to 14 years for supply or production. 

End

Steve DeAngelo Calls for the Toppling of Corporate Cannabis

9/30/2022

by

Steve DeAngelo — the Founder of Harborside, Founder of The Last Prisoner Project, author of ‘The Cannabis Manifesto,’ and a long-time cannabis advocate, entrepreneur, and investor — released an op-ed this week across multiple cannabis publications calling for the industry to reject the pyramid-shaped business model prioritized by large cannabis corporations and multistate operators.

Titled Save the Cannabis Industry: Topple The Pyramids!, the article describes the blissful pre-legalization era of the California medical market — a time when the industry “worked in its basic purpose of providing high quality cannabis at affordable prices, and providing all of its participants with an adequate income and dignified lifestyle.”

But “everything changed,” DeAngelo writes, after California voted to legalize adult-use cannabis. He describes the collapse of California’s legacy market as most medical growers were locked out of licenses, the advent of corporate finances, and the emphasis these newcomers placed on the ability to scale. The article also describes the costly and slow industry roll-out in Canada, where big players started big moves to capture large sections of the federally legal industry. “In Canada, only 20% of cannabis produced… since 2018 has actually been sold,” he writes. “80% was of such low quality that it had to be destroyed or is still warehoused — resulting in the loss of $11 billion Canadian dollars of investors’ money.”

Rather than continuing down this path of wasting millions upon millions of dollars trying to gobble up a market share that will ultimately still be dwarfed by the unfettered, unregulated marketplace, DeAngelo dreams of the industry’s return to small businesses. “Thousands of legacy, artisan producers could get into the industry without the need for crazy amounts of capital,” he writes. And instead of a handful of multi-state operators jostling for brand awareness, he imagines cute tourist trap villages full of cannabis artisans, or even just a digital marketplace for cannabis cultivators to connect directly with consumers — something like “an Etsy for weed,” he writes.

That same sentiment was reflected recently in a federal proposal by U.S. Reps. Jared Huffman (D-CA) and Earl Blumenauer (D-OR) which seeks to let small-scale cannabis cultivators operate on a direct-to-consumer model once the plant is finally legalized nationwide.

And were that plan realized, big cannabis companies “would be freed from the thankless and impossible task of producing high quality cannabis in massive facilities,” DeAngelo writes. “They could stop disappointing their investors and focus instead on an achievable goal: providing the financing, infrastructure, and marketing capacity that small producers will need to succeed.”

In an interview with Ganjapreneur, DeAngelo said that while the industry’s failures had become a “source of extreme heartbreak” for him in recent years, he reached his tipping point after someone asked him whether it was even ethical to be encouraging legacy operators to be coming into such a broken system. The question surprised and stuck with him:

“Part of what I recognized when I did my analysis is just from a numerical point of view, the deck is stacked against the legacy community. Even if every cannabis license in the country that exists today went to a legacy operator, most legacy operators still wouldn’t be licensed because there are so few licenses. So if we really want to create significant meaningful room in the legal market for the legacy players, we need to start replicating the same structures that we had in the legacy marketplace.” — Steve DeAngelo, in an interview

When asked about getting cannabis investors and venture capitalists on board with changing the status quo, he recommended they “learn from what’s already happened.”

“Over the course of the last five years, the scaled-up model … has lost 11 billion dollars of investors’ money,” he said. “So if you feel like losing more money, go ahead and keep buying into that model which has proven not to work.”

Instead of buying up more licenses or pursuing regulations that lock up the supply chain and create even more artificial bottlenecks for high-quality product, DeAngelo recommends investors look instead to other sections of the cannabis economy such as the federally legal hemp or cannabis tourism industries.

But until the cannabis industry has seen that “mutually beneficial reset,” the boom-and-bust cycle will continue, he said.

End

Japan Health Ministry Panel Recommends Allowing Cannabis Medicines

9/30/2022

by

A health ministry panel in Japan on Thursday said that the nation should allow the use of cannabis-based medicines, while also suggesting strengthening laws on cannabis use, Reuters reports. While the recommendation could lead to a historic change in Japan’s zero-tolerance drug laws, non-medical cannabis use would remain outlawed.

Japan’s government has been debating legalizing cannabis medicines, the report says, and the panel said the government should pass those reforms. Currently, the epilepsy drug Epidiolex is undergoing clinical trials in Japan but the country’s cannabis laws would need to be revised in order to allow patients to access the drug. 

According to a National Police Agency report, Japan saw a record 5,482 people involved in cannabis-related criminal cases in 2021, an increase of 448 from the previous year, with 70% of offenders in their 20s or younger. Overall, 5.6 per 100,000 people were involved in cannabis-related offenses in 2021, which is nearly double the 3.0 rate in 2017. 

Japan’s Cannabis Control Act criminalizes the import, export, or cultivation of cannabis and simple possession carries a sentence of up to five years, according to the law firm Ohara & Furukawa. Possession with the intent to profit is punishable by up to seven years imprisonment and/or up to a 2,000,000 yen fine. Growing, importing, or exporting cannabis in Japan can be punished with up to seven years in prison, and engaging in any of those acts with the intent to profit carries a punishment of up to 10 years imprisonment. 

In a survey of 829 drug offenders by the National Police Agency, more than 70% said they did not believe cannabis is harmful. 

The health ministry report noted that just 1.4% of people in Japan had ever consumed cannabis, compared to 20-40% in Western countries. 

The recommendation by the panel was based on meeting medical needs and harmonizing Japan with international standards, the report says. The reforms would apply to cannabis products whose safety and efficacy were confirmed under laws governing pharmaceuticals and medical devices. 

End

Former Green Thumb Industries Employee Files Sex and Age Discrimination Lawsuit

9/30/2022

by

A former employee at Green Thumb Industries (GTI) has filed a sex and age discrimination lawsuit against the company, according to Green Market Report. Carrie Baker, who worked at a Rise dispensary in Pennsylvania and is in her mid-50s, said she was passed over for a shift supervisor position in favor of a much younger and less qualified male co-worker prompting her to file a complaint with the Pennsylvania Human Relations Commission (PHRC) in 2018. 

Once she filed the PHRC complaint, Baker said she began receiving unfair and disproportionate disciplinary actions at work, which would lead to her eventually quitting in June 2019, the report says. 

She then filed a complaint with the U.S. Equal Employment Opportunity Commission (EEOC) in February 2020. The EEOC announced they closed their investigations into the PHRC complaint and the EEOC complaint in late June, noting they were not issuing a determination and issued Baker her suit rights. She then filed a lawsuit on September 22, the report says.  

Baker is now working in the medical cannabis division for Pennsylvania’s Department of Health.

In 2021 and 2022, GTI was named to Crain’s Chicago Business Fast 50 list and Best Workplace by MG Retailer magazine in 2018, 2019, and 2021. It has 77 open dispensaries in 15 states and employs more than 4,000 employees, the report notes.

End

New Mexico Judicial Branch Seeks Changes to Cannabis Expungement Process

9/30/2022

by

New Mexico’s judicial branch is seeking to change the state’s rules for expunging cannabis convictions, the Albuquerque Journal reports. Supreme Court Chief Justice Shannon Bacon said the program should require individuals to file their own applications for expungement rather than requiring the judicial branch to identify the cases.  

“We think there’s a more straightforward and simplistic way to handle this that will take what has been an incredibly onerous process off the judiciary and put the control in the hands of the person that’s had the conviction.” — Bacon, during a meeting of the legislative Courts, Corrections and Justice Committee, via the Journal 

The expungement provisions were included in the Legislature-approved adult-use cannabis law. Bacon hopes lawmakers will address her concerns during the state’s upcoming 60-day session. 

In practice, Bacon said forcing the judicial branch to review criminal records for expungement eligibility has proven unmanageable since many individuals with cannabis-related convictions were also convicted of other crimes. She added that many prosecutors and law enforcement agencies, especially in southeast New Mexico, have used an objection provision included in the law to try to prevent cannabis convictions from being expunged from some records. 

“Judges are spending untold hours addressing objections to this process,” she told the committee, “whether there’s a cannabis charge or not.” 

Barry Massey, spokesman for the New Mexico Administrative Office of the Courts, told the Journal that there is not yet available data as to exactly how many residents have had their cannabis-related convictions expunged since the law took effect and that there was no data as to the number of objections filed by prosecutors in advance of a July 1 deadline. 

End

Missouri Association of Prosecuting Attorneys Urges Voters to Reject Cannabis Legalization

9/30/2022

by

In a position paper released Thursday, the Missouri Association of Prosecuting Attorneys (MAPA) urged voters to reject the constitutional amendment to legalize cannabis in the state. The organization argues that if the amendment is approved, the state’s courts would be required to allow people to continue using cannabis even if they are involved in fatal accidents while driving under the influence.

In the paper, MAPA cites a September 2021 Rocky Mountain High-Intensity Drug Trafficking Area report which claims that since adult-use cannabis legalization was legalized in 2013 in Colorado, traffic deaths in the state in which drivers tested positive for cannabis increased by 138%. MAPA says that under the amendment courts would be barred from prohibiting cannabis use by drivers involved in fatal accidents and by those on probation and parole.

“Under Amendment 3, our legislature could not even set a maximum limit for marijuana in the bloodstream, while Colorado does. Amendment 3 is dangerous and makes drugged driving tougher to prosecute than drunk driving.” — MAPA, Amendment 3 Legalizing Recreational Marijuana Dangerous for Missouri 

The organization describes the proposal as “more than thirty pages of mischief” and alleges that it fails to protect “children from dealers in black market marijuana.

“While a person under 21 is not to possess recreational marijuana, a dealer can give or sell to middle schoolers and face only a ‘civil penalty’ of $100,” the organization alleges. “Prosecutors do not enforce civil penalties. Amendment 3 is silent on who would. Parents may be responsible for suing violators for this ‘civil penalty.’ This is not a deterrent. It is an incentive to ignore the safety of our kids.” 

MAPA says that because the reforms are a constitutional amendment any changes to the law could only be made in a presidential election year with 60% of voter support.

In a statement to the St. Louis Post-Dispatch, John Payne, campaign manager for Legal Missouri 2022, pushed back against the claims that selling or giving cannabis to children would only be met with a civil penalty were the amendment approved, and that it would effectively legalize driving while under the influence of cannabis. 

“Under Amendment 3, both driving under the influence of marijuana and selling marijuana outside the regulatory system remain illegal,” he said, adding that individuals who sold cannabis to middle schoolers would still face felony drug charges under Missouri law. 

“Amendment 3 creates a thorough system of regulation,” he said, “which will protect public health and safety far better than our current illicit and unregulated system.”

End

Sitka Legends: Combining Talent from Multiple Micro Cultivators

9/29/2022

by

As the Canadian cannabis industry takes shape, small growers are struggling to survive and many have lacked the means to even enter the market. Vancouver Island-based Sitka Legends wants to change that. The micro-park leases cultivation spaces on its 55-acre industrial parcel to micro-cultivators. Growers can then sell high-quality wholesale flower back to Sitka where it is processed, packaged, and sold in Sitka retail stores in a relationship that both parties have found successful.

The brand’s Bruce Banner is one of the longest-running SKUs on the market. They accomplished that without any marketing or data agreements, their sole focus has been on operations. Sitka CEO Michael Forbes told Ganjapreneur that the model is working, but “You have to have all the stars align for this.” To pull off the micro-park, Forbes needed the capital to build out the units without traditional financing, zoned industrial land which is in short supply, and local access to an abundance of legacy growers.

Forbes applied for an LP license as soon as he was able to under the new law, but his application took a long time and during the waiting process, the laws changed. When micro-cultivation regulations were added, he already owned industrially zoned land (which is expensive to hold and hard to come by) so he decided to re-zone the parcel as a cannabis micro-park. Once they were approved, Sitka interviewed more than 100 cultivators prioritizing those who could grow high-quality cannabis and from that pool of applicants, they chose the ten micro-license holders who are currently operating at the park today.

At the time, Carl Ketch, CEO of Sitka micro-cultivator Quadessence, was navigating his entry into the adult-use market after six years of growing medically. He searched for a municipality that would allow micro cultivators but after finding one, he learned that building the operation out and finding industrial zoned land would require a multi-million dollar investment. Eventually, they were selected to partner with Sitka, which brought down their required investment from over $3 million to $1.2 million. Ketch said that at the time, it was the only way he could make Quadessence happen. “If we didn’t partner with Sitka we wouldn’t be in the legal industry, I can tell you right now that there’s a lot of people in Canada that wish they were in our shoes.”

Quadessence is currently producing about 110 lbs of high-quality wholesale flower every 37 days. They grow a few signature strains and are always testing new phenotypes to isolate genetics with high cannabinoid content that produce large quantities of flower. About 80% of their wholesale flower is sold to Sitka and the rest is sold independently, and they’ve yet to be challenged to move product. All cannabis sold to Sitka is packaged and branded as Greenade or Sitka, featuring a photo and small bio of the grower on the back of each package.

Sitka takes a passenger seat in managing individual micro-cultivations, recognizing that every grower uses their unique methods. They simply provide the space outfitted with electricity and a roof rain catchment system that covers their water usage for most of the year – in dryer months, Sitka trucks in water for the growers. Some of the most essential support comes through processing, packaging, and sales. “This is a very complex business to get off the ground if you are a small entrepreneur. The Sitka model splits it up into two so the grower does what they do best which is growing, then Sitka does the packaging, processing, and sales,” Forbes said.

Ketch expresses that their success is only possible because they dialed in their growing methods and came into the space with cannabis cultivation knowledge. “The thing about growing cannabis is that it’s literally feast or famine,” he said. “If you’re not growing a product that is high enough quality to get the bigger dollar, your business can go under really fast. Same thing if you’re not getting the yields. It’s a lot harder to do than it is to put on paper.”

After speaking with Forbes and Ketch, it’s clear that this partnership is working well for both parties but it has yet to be duplicated in Canada or the United States. Even so, Forbes is convinced that craft growers will soon take up a large market share, much like the beer industry when craft brewers could legally enter the space. “With time, as the laws and the rules and the market shakes out, I think you’re going to see a shift to smaller, craft batch cannabis in the marketplace. I think Sitka is at the front of that charge.”

This year, Sitka is looking forward to Farmgate sales which would allow licensed producers to sell directly to consumers, and when permitting goes through, they will start the process of expanding to build out more cultivation facilities.

At the end of our conversation, I had to ask Ketch: if he could go back, would he take on this partnership with Sitka again? “There wouldn’t have been a different path,” he said. “I would have done it every time, and I’m glad that we did for sure.”

End

Idaho Bans Hemp Ingredients In Animal Feed and Pet Food

9/29/2022

by

The Idaho State Department of Agriculture (ISDA) is banning hemp and hemp-derived ingredients in animal feed, pet food, and supplements sold in the state beginning November 1. The move is in consensus with the U.S. Food and Drug Administration (FDA) and Association of Animal Feed Control Officials (AAFCO) which have not approved the use of hemp or hemp-derived ingredients in animal feed. 

“Safe levels of hemp and hemp-derived products in animal feed have not yet been established under federal or state law. As such, these products are not approved feed ingredients and cannot lawfully be added to or incorporated into commercial feed. This includes feeds, treats and remedies intended for pets, livestock, or any other animal.” — ISDA in a July 20 memorandum  

Idaho legalized hemp in 2021 but the ISDA notes that the law “did not legalize hemp in every setting or product type.” The agency indicated it is “working with new hemp licensees and animal feed companies to understand what is legal in the state.”  

“Interest in hemp animal feeds and remedies has grown significantly, and these products are known to be available online and in retail stores,” the ISDA says in the memorandum. “We recognize that some states have adopted laws and rules that allow for hemp to be included in human and animal foods.” 

The agency said it would begin inspecting for hemp and hemp-derived animal feeds starting November 1 and violations will be subject to a stop-sale order and possible “further action” from regulators.  

End

Nevada Cannabis Regulators Reject Testing Lab’s Bid to Dismiss Disciplinary Action

9/29/2022

by

The Nevada Cannabis Compliance Board (CCB) on Tuesday voted unanimously to reject the motion to dismiss disciplinary action by a cannabis testing laboratory accused of intentionally manipulating testing results to inflate THC levels, the Las Vegas Review-Journal reports. Lettucetest LLC, formally known as Cannex Nevada LLC, now faces disciplinary action and could lose its business license and be prohibited from operating in the industry for a decade. 

The facility first faced a complaint from regulators in January 2021, including more than a dozen violations, the report says. The board found that the testing company also passed samples tainted by microbial contaminants in addition to misreporting THC levels.  

“Rather than protecting consumers through accurate and honest testing, Cannex implemented testing processes that were designed to protect the monetary assets of their clients without regard for consumer safety.” — CCB in the January complaint 

Lettucetest had argued during a special board meeting earlier this month that the charges should be dropped due, in part, to a technicality that since the violations occurred prior to the board’s formation, it doesn’t have the authority to charge them, the report says.  

The facility has previously been suspended twice in 2019 and 2020 when it was discovered it had passed tainted products which were then sold at retail dispensaries. The Nevada CCB complaint indicated it found 232 instances of unapproved retesting of products that had initially failed testing for microbials. 

The company could also face a $62,500 fine.   

End

Libertarian Iowa Gubernatorial Candidate Releases Pro Cannabis Legalization Ad

9/29/2022

by

In a new ad titled “Dear Kim, WEED,” Rick Stewart, the Libertarian gubernatorial candidate in Iowa, called out Gov. Kim Reynolds (R) over her position on cannabis legalization.  

In the ad, Stewart apparently stood a few miles from the border of Illinois and Iowa and stated that were he to buy cannabis in Iowa he would be “buying it from a crook” but were he to buy it just an “over the bridge” he’d be “buying it from a reputable businessperson.” 

“Our laws today in Iowa put people in rape cages because they smoke marijuana. You’re going to lose your college scholarship, you’re going to lose your job, you’re going to lose your kids, you’re going to lose everything because in Iowa we think cannabis is a gateway drug. Well, gateway to what?” — Stewart in the ad 

Stewart points out that former presidents Barack Obama, George W. Bush, Bill Clinton, and Vice President Kamala Harris have each admitted to consuming cannabis at some point in their lives. 

“A gateway to what?” he muses in the ad, “to the White House?”   

Stewart also appears in front of a corn field and asks why he can grow corn but “can’t grow weed?”  

“They’re both plants,” he says. 

In the ad, Stewart points out cannabis plants growing in a ditch (it’s unclear whether the plants are growing in Iowa or Illinois) and says that “God put them there.” He follows up by asking “Kim” why she thinks she is “smarter than God.” 

“If a farmer wants to grow corn, let him grow corn. If a farmer wants to grow weed, let him grow weed. So, when is the drug war going to end in Iowa, Kim?” he asks before facing the camera and answering his own question. “Easy answer. The day I’m governor.”  

In a July poll from the Des Moines Register/Mediacom Iowa, Stewart had the support of just 5% of respondents. 

End

Nidhi Lucky Handa: Consumer-Friendly Cannabis Products Under a Multistate Lifestyle Brand

9/28/2022

by

LEUNE is a California-based cannabis company that has expanded into Arizona and Maine since its launch. The lifestyle company was founded by Nidhi Lucky Handa, a former celebrity talent manager, and a luxury brand communications expert. LEUNE brands and sells packaged cannabis flower, one-time-use vape pens, and rosin gummies.

In this written interview, Nidhi breaks down the reasoning behind LEUNE’s branding and market expansion, how they source their products, the quality control that goes into sourcing and branding the company’s consumer packaged goods across multiple states, and more.

Scroll on to read the full interview!

Ganjapreneur: What have you enjoyed about starting a business? Alternatively, what are the hard parts of entrepreneurship that can be glossed over?

Nidhi Lucky Handa: Great question – much of the time founder life creates tunnel vision and laser focus on moving forward, so it’s nice to pause and reflect on the highs as well as the…challenges!

The parts I love are so easy to see in the rear view – building a team, a culture, getting the big ideas from paper to production, celebrating the smallest of victories – but the reality is, I’m learning now that the best parts are actually in the process, in the now. I feel so immensely grateful to have a business in this dynamic industry and to have the opportunity to tell the stories that are important to me with a team I adore and learn from everyday.

The harder parts are the ones you’d expect – making choices that are in the best interest of the company even when they’re at the expense of a part of the vision. It’s a constant pivoting exercise running a business in an emerging industry and that means (sometimes) letting go of the passion projects or putting them on ice for a later time.

When you couldn’t find adult-use products catered to women on dispensary shelves, you identified a gap in the market and decided to create LEUNE. How do you believe LEUNE has filled this gap, and how does its branding and marketing advance this concept?

I was (and still am) less interested in gender and more interested in building something for a consumer (like me and my peer group) who is excited about legal weed, but isn’t/wasn’t being spoken to. I wanted to build something that was aesthetic and stylish, well-priced and high on quality – that’s where LEUNE was born.

We’ve been thoughtful about everything from consumer arc to buying habits. We’ve paid close attention to the consumers who want to initially just dip their toe in the pond but quickly convert to regular customers – we’ve listened closely to what makes folks stick around and what makes them leave.

I’ve put a strong emphasis on the creative spirit at LEUNE because that’s what resonates with me as a consumer. Our campaigns are ethereal, beautiful and relatable all at the same time.

What branding components signal to the ideal cannabis consumer that LEUNE products are for them? How else does the brand engage the consumer in the retail store?

That’s a good question- I believe that consumers who are drawn to LEUNE branding are attracted to the clean, modern, color-blocked aesthetic and simple overall architecture of the brand.

What attracted LEUNE to Maine as you expanded into new markets?

Maine is close to my heart as a Massachusetts native. I spent many a summer holiday in Portland growing up. The food and craft culture are all in such perfect alignment with who we are as a brand – small, unique, happily in our own skin. We were thrilled when the stars aligned and the opportunity presented itself. I love shopping the dispensaries in Maine and soaking in the passion for the plant that the local market clearly hones in on.

Did LEUNE complete any market research before releasing products in Maine? What research tools or resources were helpful during the expansion?

Yes, of course! We do so for every market. We look carefully at existing brand presence, product assortment, price points and quality. In order to build out a plan and product assortment that fits well for the market in question we do extensive research. In terms of tools, we talk to experts in the market, visit stores and go through retail menus – it’s the most accurate and up to date way to get this kind of data – albeit very time consuming.

What is Honestly Grown, and what moved the team to create the publication?

Honestly Grown is LEUNE’s quarterly lifestyle magazine. It focuses on raising the bar surrounding the conversation on cannabis. With activism and social justice at its forefront, Honestly Grown aims to bring awareness to the reader through interviews, anecdotal submissions, art and education.

We were inspired to create a magazine because we wanted to use our creative resources to highlight the importance of social justice in cannabis, such a s restorative justice for those still currently incarcerated for nonviolent cannabis crimes. We are also aiming to destigmatize conversations around cannabis and promote conversations that normalize the plant in every way.

Why did the brand choose to expand its product offerings, and what dictated that the new product would be a gummy candy?

From inception it was always clear to me that LEUNE would be vertical agnostic – even at launch with four SKUs, it was two all-in-one vapes and two pre-rolls.

We are proudly a consumer-first brand – and in an industry that is so young and constantly evolving, we want to listen to the consumer and understand what, why, where and how often they want to consume. In order to do that, we have to give them choice and pay attention to the evolving use-case of different form factors.

As for the gummies – those took the most R+D, time and iteration to get right, and I couldn’t be prouder. Rosin, gluten free, vegan, taste GREAT…they check all the boxes of a discerning consumer.

Who is your manufacturing partner in California? How do you oversee quality control using an offsite manufacturing facility?

We’ve worked with over a dozen facilities across the state to ensure LEUNE products stay on the shelf! We’ve learned so much about the importance of super buttoned up, specific SOPs and rigorous QA/QC check-ins over the years. It’s essential that brands stay vigilant and particular about the consistency of the products to ensure that customers have a great experience again and again.

How do you manage quality control as you’ve expanded into new markets? Can a consumer expect the same quality pre-roll from a California and Arizona dispensary?

As a brand this is of utmost concern and care. We vet our partners through-and-through.

Does LEUNE use sales teams, software, or a combination of the two to reach its retail partners?

It looks a little different in every market. Here in CA, LEUNE products are distributed and sold by a full service distributor. With that relationship we have access to a robust team of professionals throughout the state who can reach all corners of California.

When a new store puts in an order, does the brand educate retail staff before the products hit shelves?
ABSOLUTELY! Education (at every level) is the most important part of sales in my opinion! Ensuring that the budtenders are able to speak to the UVP of the brand is essential to strong sell through and retention.

What types of cannabis products do you think will gain popularity among California consumers in the coming year, and why?

​ROSIN GUMMIES! Consumers are starting to learn the benefits of rosin in edibles – no more distillate hangover for starters. It’s a game changer and once you try a better quality product (like LEUNE Gem Drops) it’s impossible to go back.

Do you have advice for entrepreneurs interested in building a consumer-focused brand?

The cliche is true – be authentic, find a problem and fix it, know what your UVP is!

Thanks again, Nidhi, for answering our questions! Our readers can visit LEUNE.co to learn more.

End

Canopy Growth Divests Its Retail Businesses Throughout Canada

9/28/2022

by

Canadian cannabis company Canopy Growth Corporation on Tuesday announced that it is divesting itself of its retail cannabis businesses across the nation, including its stores operating under the Tweed and Tokyo Smoke banners. The company said the move reinforces its “focus on advancing its path to profitability as a premium brand-focused cannabis and consumer packaged goods company.”  

In a statement, CEO David Klein described the plan as “the next critical step in advancing Canopy as a leading premium brand-focused [consumer packaged goods] cannabis company while furthering the company’s strategy of investing in product innovation and distribution to drive revenue growth in the Canadian recreational market.” 

Under the agreement, OEG Retail Cannabis (OEGRC), an existing Canopy Growth licensee partner that currently owns and operates the company’s franchised Tokyo Smoke stores in Ontario, will acquire all Tokyo Smoke-related intellectual property. Canopy said it has also reached an agreement with 420 Investments Ltd. in which 420 will acquire the ownership of five retail locations in Alberta.  

Both transactions are subject to regulatory approvals and other customary closing conditions. 

“By realizing these agreements with organizations that possess proven cannabis retail expertise, we are providing continuity for consumers and team members. Through the best-in-class retail leadership that OEGRC and 420 have demonstrated, they will continue to serve Canadian consumers with the high-quality in-store experiences that are essential for success in a new industry.” — Klein, in a statement 

The plan will also terminate Canopy’s master license agreement with Alimentation Couche-Tard Inc. with respect to the use of the Tweed brand for brick-and-mortar retail stores operating in Ontario. 

Canopy will, however, continue to own and operate the Tweed brand.  

The company indicated that all of its retail workers would continue their employment under the new regime.  

End

New York Receives More Than 900 Retail Dispensary Applications

9/28/2022

by

New York regulators received more than 900 adult-use retail cannabis dispensary applications before the application window closed on Monday, Syracuse.com reports. The state plans to initially issue up to 150 conditional adult-use retail dispensary licenses in the first round of licensing; however, state regulators have yet to promulgate industry rules.

Individuals who qualify for the conditional licenses must have been arrested in New York for a cannabis offense (or have a family member who was) prior to March 31, 2021, and have operated a profitable business for at least two years. Licenses will also have access to storefronts that are currently being secured and will be built out into dispensary spaces by the Dormitory Authority of the State of New York (DASNY), the report says.

A Siena University poll in March found a majority of New Yorkers – 54% – oppose the plan to give the first batch of adult-use licenses to social equity applicants.

The state also plans to grant 25 licenses to qualifying nonprofits but those organizations won’t have access to the DASNY properties or the state’s $200 million social equity cannabis investment fund.

The state plans to award the licenses by region. According to Office of Cannabis Management plans, the Manhattan region is set to receive the most licenses (22), followed by Long Island (20), Brooklyn (19), Mid-Hudson (17), Queens (16), Western New York (11), the Bronx (10), Finger Lakes (9), Central New York and the Capital Region (7 each), the North Country (4), Staten Island and the Southern Tier (3 each), and the Mohawk Valley (2).

While the timeline for the rollout of adult-use dispensaries has shifted from before the end of the year to potentially the middle of next year, the report notes that state officials still expect the first conditional adult-use retail dispensary to open before year’s end.

End

Arkansas Supreme Court Approves Cannabis Legalization Question for November

9/28/2022

by

The Arkansas Supreme Court last week ruled the state’s adult-use cannabis ballot initiative can appear on November ballots, the Associated Press reports. The ruling came after Responsible Growth Arkansas asked the court to reverse an August decision by the state Board of Election Commissioners that said the measure could not appear before voters in November because of a title language technicality, despite the group having collected more than enough signatures. 

“The people will decide whether to approve the proposed amendment in November,” Justice Robin Wynne wrote in the court’s ruling.

The court had allowed the initiative language to go forward in August while it decided the case. In the meantime, state Attorney General John Thurston, who chairs the Board of Election Commissioners, agreed with the Board and said the initiative could not be considered in November. 

“We’re extremely grateful to the Supreme Court that they agreed with us and felt like it was a complete validation of everything we’ve done,” Steve Lancaster, an attorney for Responsible Growth Arkansas, told the AP. “We’re excited and moving on to November.”

Arkansas passed a medical cannabis constitutional amendment in 2016. If approved, the adult-use law would allow Arkansans aged 21 and older to purchase up to an ounce at regulated dispensaries.

The court also struck down the 2019 law that gave the Board of Election Commissioners the authority to approve ballot measure language. That task now falls to the state attorney general, the report notes.

End

Cannabis Crossing Borders: Global Flower Trade in 2022

9/28/2022

by

Editor’s note: This guest article was contributed by Michael Sassano, CEO and Chairman of the Board for Somai Pharmaceuticals LTD, a European pharmaceutical and biotech company.

As you read this, cannabis flower is soaring from country to country. That’s right — cannabis is a global market breaking through borders. As expected, lower-cost-producing countries and regions are fast becoming the go-to suppliers for higher-cost, wealthier zones. Globally, what was discussed for years is coming to fruition. Let’s consider the state of the six major worldwide cannabis growing markets: the United States, Canada, South America, Europe, Africa, Australia, and Asia.

The United States cannabis market keeps to itself

The U.S. is a series of closed state markets that do not allow the crossing of state borders with regulated cannabis products. While a small emergence of DEA-registered pharmaceutical growers that produce medical APIs can cross state and international borders as registered medicines like Groff North America, these are rare. The U.S. has continuously operated a closed pharmaceutical model.

Canadian cannabis costs negate global early entrant advantage

Canada is still the heavyweight of export and based its entire overbuilding and overgrowing models on a robust international trade future look. Unsurprisingly, money moved faster than the cannabis regulations worldwide. The public markets have suffered since 2019 from this fiscal hangover and continue to do so. Three years later, the Canadian survivors are those who have become the largest exporters and feed the local markets.

While Canadian genetics may be superior to emerging countries, their costs are much higher, and other countries have learned from their mistakes. Canada is the home base for several global leaders like Canopy Growth Corporation, who paved the paths of the worldwide market. Still, volumes and lower costs from other countries are quickly chipping away at Canada’s first-mover advantage, which spells more woes for Canadian producers.

South America works to match world cannabis demand

South America quickly adapted to the progress in cannabis of their latitudinally northern neighbors. South American market entrants understand that not only is their climate more beneficial for growing, but they can also secure labor and general costs at a premium compared to North American markets.

Uruguay emerged as the self-proclaimed global distributor for South American cannabis and made regulations beneficial to achieve that goal. Large cultivators like Fotmer Life Sciences call Uruguay home. Columbia was also proactive in supporting the cannabis trade and hosts public companies like Clever Leaves and Khiron Life Sciences Corp. They are leaders in the European Union in bringing products and distribution models to the global cannabis market. Increasingly, more and more products are making their way from South America and around the globe to feed the increasing worldwide demand for cannabis.

Outdoor farms are the cheapest and most sustainable source of cannabis but many U.S. markets have forced licensed cultivators to operate indoor-only grows.

All eyes are on the European green wave

Europe is the most-watched cannabis-growing region to date. Beneficial regulatory environments steadily increase demand, drawing growers worldwide, and local production ramped up. Countries like Portugal cemented their position as the largest cannabis cultivators and exporters in the EU early on. Portugal hosts 19 working facilities and powerhouses like Tilray Inc. It has over 100 additional pre-license applications in the works and exported over 30 tons of product in 2021 — a figure it has already exceeded in the first half of 2022. These products reach countries like Germany, the United Kingdom, and almost every EU country with good regulatory frameworks for cannabis, in addition to countries like Israel, Australia, and other emerging cannabis markets. The EU will become the second-largest regional market and a serious worldwide competitor in the next few years. All eyes are on Europe and the countries within vying for position.

Africa emerges on the cannabis world stage with significant advantages

Africa — especially South Africa and Lesotho — has become a powerhouse of large-scale growing operations designed to export into the global markets. Initially, Canopy made significant investments there, which they later divested. Still, the local market smelled green. There are roughly 70 operating licenses in the south of Africa, and their low production costs have attracted buyers in Israel, the EU and Australia. Leaders like MG Health and Highlands Investments call Lesotho and South Africa home, respectively. With countries like Morocco going legal and a robust agricultural labor force throughout the region, more African countries are expected to emerge as lower-cost cultivation facilities.

Australia has a big appetite for cannabis imports

Australia was an early adopter on the opposite side of the globe from North America. Not only does Australia have a good infrastructure for home-grown products, but demand has been so robust that they are a large importer. Australia is home to many global companies like Little Green Pharma. Their neighbors in New Zealand are expected to improve their regulatory framework, which will open more trade for Australia. Australia is expected to be a large importer as demand in the region is outpacing local production infrastructure.

Asian cannabis market rocked by Thai entry

Finally, Asia is heating up with the entry of Thailand onto the international cannabis scene. Thailand cultivators came out of nowhere this year and have been making their presence known on the global markets with boasts of the lowest cost of production anywhere in the world. There are yet to be public figures to easily verify this claim since this is all so new, but let’s have some faith and see what comes from Thailand. Unsurprisingly, countries famous for cannabis genetics pre-legal global world have the edge over northern latitude countries. South America, Africa, and Thailand are well known for having suitable climates and lower labor costs that cater to healthy cannabis growth.

At the crossroads of Europe, Africa and Asia, we would be remiss to skip over Israel’s Asian impact. Israel remains the largest market in the region with over $250 million in sales and is one of Asia’s oldest legal cannabis markets. Israel hosts global companies like Tikun-Olam and BOL Pharma.

Cannabis will continue to increasingly criss-cross the globe

Cannabis is sweeping the globe in airplanes from lower-cost producers and mature markets sharing their great genetic flower power. Demand is increasing worldwide, and growers are becoming much more agile to adapt to new markets and produce properly regulated flowers for export and import. What was once a prophecy of a greener international market is now a reality that is only growing faster and more robust.

End

Australia Fines Three Medical Cannabis Companies Nearly AUD$1M

9/28/2022

by

Australia’s drugs regulator, the Therapeutic Goods Administration (TGA), on Tuesday issued 73 infringement notices totaling $972,360 to medical cannabis companies that claimed their products could treat serious medical conditions, including cancer and epilepsy. 

MGC Pharmaceuticals Ltd was issued 23 notices totaling $306,360, Cannatrek Ltd was issued 22 notices totaling $293,040, and Little Green Pharma Ltd was issued 28 notices totaling $372,960 for the alleged unlawful advertising of medical cannabis products on their websites and social media platforms. The TGA said that some of the ads in question “suggested or implied that particular medicinal cannabis products were recommended or approved by a government authority.” 

“Advertising of prescription-only medicines directly to consumers undermines the doctor-patient relationship and may create an inappropriate demand for particular medicines which may not be right for the individual. Businesses can advertise prescription-only medicines exclusively to health professionals as long as those advertisements are not accessible to the public.” — TGA in a press release 

The TGA said, “the use in advertisements, of claims about a serious disease or condition, is also unlawful without express permission from the TGA because Australians facing a serious disease or condition are a particularly vulnerable consumer group.” 

In a statement to the Guardian, MGC said it “cooperated fully with the TGA to remedy the issues raised, including removing all posts of concern from its social media channels, some of which were third-party posts, and placing the company’s website into maintenance.” 

The company’s website on Wednesday remained under maintenance with a note that it “is going through a rebranding.” The websites for Cannatrek and Little Green Pharma remain online and functional. 

All dollar figures in AUD. 

End

Hempcrete Approved for U.S. Residential Construction

9/27/2022

by

Hempcrete was approved for the model U.S. residential building code during a hearing last week overseen by the International Code Council (ICC), HempBuild Magazine reports. The material was approved as an appendix for the 2024 International Residential Code (IRC), which governs U.S. residential building codes for 49 out of 50 states.

The new code, set to be published formally in 2023, will feature Hemp-Lime (Hempcrete) under “Appendix BA.” Specifically, hempcrete was approved as a non-structural wall infill system similar to cob and straw bale construction, according to the report. The approval applies to one- and two-family dwellings and townhouses and should increase the availability of hemp-based building materials and facilitate greener construction projects around the U.S.

Hempcrete is a popular alternative to concrete that is made from a mixture of hemp stalk hurds and lime. It creates a fire-resistant fibrous insulation wall that also acts as a moisture regulator. Additionally, because it is made from hemp — an organic material — hempcrete is considered a carbon-sequestering construction material which further improves its sustainability.

The successful application to certify hempcrete for the IRC was submitted by the U.S. Hemp Building Association after having raised more than $50,000 and working alongside a committee of civil engineers, hemp-lime builders, architects, and other experts. CoExistBuild’s Ana Konopitskaya, a Pennsylvania-based architect who helped write the application, told HempBuild Magazine that “including hemplime” in U.S. residential construction codes was “of paramount importance.”

“It will allow architects like myself, focused on sustainability, to specify this product in any municipality across the U.S.” — Konopitskaya, via HempBuild Mag

While hempcrete will be available to most home construction projects in the U.S., it remains prohibited from commercial projects until at least 2025 — that is when officials are set to renew the International Building Code (IBC), which governs any occupancies not covered by the IRC.

The construction material has long been used in France and more recently in Canada but federal hemp prohibition in the U.S. kept it out of official building codes for decades despite its uniquely sustainable properties.

The U.S. legalized hemp at the national level in 2018.

End

Missouri Cannabis Sales Could Hit $300M During First Few Years

9/27/2022

by

Missouri’s adult-use cannabis industry could generate between $250 million and $300 million in sales during the first few years of sales, according to Beau Whitney of Whitney Economics, who also estimates the state industry could grow to $800 million and $900 million by 2025 as individuals shift from the unregulated market to the regulated market.

“Consumers are extremely price sensitive when it comes to cannabis purchases. But they’re willing to pay a premium to do things in the legal market, just as long as that premium is not excessive. The sweet spot really is 10 to 15% premium above the illicit market price.” — Whitney to KCTV5 

If the sales reach those initial projections, Whitney said, the state would reap about $81 million in taxes over the first few years alone.

Currently, the unregulated cannabis trade in Missouri is worth about $2 billion, the report says. 

Missouri voters in November are set to decide whether to legalize cannabis for adult use and internal polling by advocacy groups suggests the reforms will pass. Separately, a SurveyUSA poll released in May found 62% of Missourians back the reforms, including 76% of Democrats (14% opposed), 49% of Republicans (38% opposed), and 66% of independent voters (20% opposed). 

The initiative has received pushback, though, from a coalition backed by Democratic state Rep. Ashley Bland Manlove who argues that “people from politicians to Bob on the street didn’t know the details” on the proposed constitutional amendment, which she described as exploitative. The organization, Canna Reform Coalition, also counts members of cannabis businesses as its backers. The group is criticizing the proposed constitutional amendment for not offering social equity provisions and for civil penalties included in the question, including a $100 fine for smoking cannabis in public.

End

South Carolina Farmer Sues State Agencies Over Destroyed Hemp Crop

9/27/2022

by

A South Carolina farmer is suing several state agencies claiming that they conspired to deny him his due process rights after authorities destroyed his hemp crop in 2019, which was cultivated in unregistered fields, the Associated Press reports. In the lawsuit, John Pendarvis argues that the South Carolina Law Enforcement Division (SLED), Department of Agriculture, and attorney general’s office denied him due process after agriculture department officials found unreported hemp crops during a check of his property. 

Pendarvis claims in the lawsuit, which was filed on September 16, that he had filed an amended hemp application with regulators that indicated droughts had forced him to move his crop’s location. However, Derek Underwood, assistant commissioner of the Agriculture Department’s Consumer Protection Division, claimed that Pendarvis’ moving of the crop was a “willful violation” of the state’s hemp farming program, according to emails shared in the complaint outlined by the AP. Underwood subsequently sought approval to destroy the crop, the report says. 

In the lawsuit, Pendarvis says the legal mechanism for seeking such approval is unclear which is why he argues the government violated his due process rights. Under the state’s hemp law, registered farmers must report their hemp crops’ coordinates to the South Carolina Department of Agriculture and cannot grow plants that exceed the federal THC limits. Farmers are also required to correct any negligent violations. 

Pendarvis, a fourth-generation farmer, is the first person charged with a misdemeanor crime under the North Carolina hemp farming program. 

In emails included in the lawsuit, South Carolina Solicitor General Adam Cook describes the enforcement mechanism in the state law as “ultra-murky,” giving “no direction whatever to law enforcement.” In the emails, the state attorney general’s office advised the South Carolina Law Enforcement Division to “seek judicial authorization” to ensure Pendarvis “receives due process,” according to the documents reviewed by the AP. 

After SLED was unable to get a local judge to sign their seizure and destruction order, agents – without detailing their intent to destroy the crop – secured an arrest warrant for Pendarvis from another magistrate. Emails included in the complaint show that SLED agents took this action despite the original judge offering to hold a hearing in the matter, which SLED’s general counsel Adam Whitsett declined.  

Officials in the attorney general’s office then amended their guidance to agree with SLED’s interpretation that the hemp farming participation agreement – which allows the destruction of crops grown in an unlicensed area – amounted to the “valid consent” necessary to pursue their plan. Pat McLaughlin, Pendarvis’ attorney, told the AP that nowhere in the participation agreement do farmers waive their right to challenge such claims. Pendarvis also claims the agents denied his repeated requests to call his attorney.  

In an emailed statement to the AP, South Carolina Attorney General’s Office Communications Director Robert Kittle said the lawsuit “lacks merit.” 

End

Few Using Services Provided Under Oregon’s Drug Decriminalization Law

9/27/2022

by

Following the drug law reforms in Oregon – which decriminalized possession of all drugs and sent millions of dollars to drug treatment programs – few individuals are utilizing services to help them with their addictions, according to an Associated Press report. According to Oregon Health Authority (OHA) figures, of 16,000 people who accessed services during the first year of decriminalization, only 0.85% entered treatment, 60% received “harm reduction” like syringe exchanges and overdose medications, 15% got housing assistance, and 12% obtained peer support.

Steve Allen, behavioral health director of the OHA, said during testimony before lawmakers last week that the state has sent more than $302 million to facilities to help people with their addiction or help them use drugs safely, such as needle exchanges.

The voter-approved law is the first of its kind in the nation and supporters argued that decriminalization would keep people out of prison and urge them to seek treatment; however, since the passage of the reforms, fatal overdoses increased by nearly 20% over the previous year, the report says.

Under the law, people caught possessing drugs receive a citation, with the maximum $100 fine waived if they call a hotline for a health assessment. However, an investigation by Oregon Public Broadcasting found that most of the more than 3,100 tickets issued so far have been ignored and few people have called the hotline.

During his testimony to lawmakers, Tera Hurst, executive director of Oregon Health Justice Recovery Alliance, which is focused on implementing the voter-approved law, called the millions of dollars in funding – which comes from cannabis taxes – a “pivotal moment” and that as the program is still in its nascent stages it’s important to focus on “just building a system of care to make sure that people who need access can get access.”

“Measure 110 is launching,” he said, “and will provide critical supports and services for people, families, and communities.” 

End

Nation’s Largest B2B Event for BIPOC Cannabis Professionals Returns to New Orleans

9/27/2022

by

From November 3-5, Black CannaBiz Expo will feature 40+ influential speakers and welcomes company partners including Curaleaf, Wana Brands, 5th House Farms, Cresco Labs, and others

NEW ORLEANS, September 27, 2022 – Black CannaBusiness Conference LLC is pleased to announce the third annual Black CannaBusiness Expo & Conference (“Black CannaBiz Expo”), the only B2B conference for Black and Brown professionals in cannabis. The event, which attracts the largest gathering of BIPOC cannabis professionals, takes place November 3-5, 2022 in New Orleans to focus on the Southern Gulf Coast as regional changes in cannabis legalization take hold.

Black CannaBiz Expo & Conference is a first-of-its-kind networking, education and career-advancing conference and expo specifically curated for BIPOC individuals in the cannabis space. The business community-focused conference will feature keynote addresses and fast-paced workshops and break out sessions presented on an open platform for quick, tangible takeaways. More than 40 influential speakers will take the stage for enlightening and educational discussions focused on the state of BIPOC cannabis business, from social equity and policy, to capital funding and cultivation.

Attendees will have the opportunity to connect with solution providers and go-to experts in cannabis during the Black Cannabiz Expo, the largest expo for BIPOC exhibitors.

“As we head into our third year, we are excited to be introducing new speakers as well as unique and exciting networking and educational opportunities for our exhibitors and attendees,” said Kristi Price, Founder and CEO of Black CannaBiz Expo. “Our goal every year is to create a safe and productive place not only for people of color, but for everybody in the cannabis industry that believes in inclusion and justice.

“At Curaleaf, we are looking for ways to continue expanding access to our company and the cannabis industry at large,” said Raheem Uqdah, Director of Corporate Social Responsibility at Curaleaf. “Minority communities have shouldered the burden of cannabis’ prohibition and deserve to reap the benefits of regulation both medically and financially. We are honored to be a part of the Black CannaBiz Expo and its continued success as a hub of learning and networking for BIPOC professionals who are looking to be a part of this incredible industry.”

Adding to the depth of the event, is the list of keynote and featured speakers that includes some of the best and brightest BIPOC voices in cannabis. The conference is excited to announce Chris Ball, the Founder of Ball Family Farms, Inc., the first vertically integrated, minority-owned, Social Equity commercial cannabis facility in Los Angeles, Toi Hutchinson President and Ceo at Marijuana Policy Project and Gary Chambers Jr., US Senate candidate and , native son of Baton Rouge, Louisiana. The event will also welcome Mr. John Bailey, CEO & Principal of The Bailey Consulting Network, Chair of the Colorado Black Round Table and the Founder and Lead Convener of the Black Cannabis Equity Initiative (BCEI).

Black CannaBiz Expo will be hosted at the recently renovated, state-of-the-art Ernest M. Morial Convention Center in New Orleans, Louisiana. Tickets are on sale now and can be purchased on the Black CannaBiz Expo website. To learn more about attending, exhibiting, sponsoring or speaking at Black CannaCon, please visit https://blackcannabizexpo.com or email support@blackcannabusiness.com. Submissions for speaker proposals close September 30th, 2022 and applications can be found here.

About Black CannaBusiness Magazine
Black CannaBusiness Magazine is a subsidiary of KRMA Media Inc, a Black woman-owned multi-media company helping Black professionals accelerate their involvement in the cannabis industry through the distribution of curated B2B content, the production of experiential events and the development of original video programming. Our sponsors prioritize diversity and are committed to doing their part to create a more inclusive industry.

About Curaleaf
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 21 states with 136 dispensaries, 26 cultivation sites, and employs over 6,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Media Contacts
Black CannaBusiness
Octane PR
Sophia Thay, Director of Business Development
media@OctanePublicRelations.com

 

###

End

Bloom Announces 90% Increase in Cannabis Trimming Speed

9/27/2022

by

Artificial Intelligence Doubles Human Processing Capabilities

WOBURN, MA – Bloom Automation Inc., an agri-tech company specializing in cannabis trimming equipment, today announced a 90% increase in their trimmer’s processing speed, as enabled by new artificial intelligence algorithms.

The Bloom trimmer — which uses a robotic arm and visual sensors to trim leaves from cannabis flowers — incrementally improves its capabilities using machine learning. The leap in performance is a culmination of a larger dataset of images, thousands of hours of software R&D, and a faster graphic processing unit (GPU).

“Our updated machine processes cannabis at approximately twice the speed of a human trimmer, moving us that much closer to Bloom’s vision of hand-trimmed-quality at an industrial scale,” said Jon Gowa, CEO and Founder of Bloom.

Bloom Automation’s system requires little attention from the operator, allowing personnel to perform additional tasks while the machine runs. Gowa estimates that a single technician can operate six Bloom trimmers — effectively performing the work of 12 employees.

“The AI has expedited the analysis of a frame of data from 15 seconds to 1 second, now down to just 0.1 seconds,” said Gowa. “It can distinguish flower from leaf almost instantaneously — hence the advancement in speed.”

Unlike other machine trimmers and standard hand-trimming processes, the Bloom system trims without detaching the flowers from the stem. Each stem is suspended vertically while a robotic arm shears away leaves. Gowa reports that this method prevents damage to the valuable flowers and preserves the plant in a form that is as close to its original state as possible.

For more information about cannabis trimming or the science behind Bloom Automation, contact Shannon Hagerty, Marketing and Business Associate, at info@bloomautomation.com.

End

Georgia Awards Two Medical Cannabis Licenses

9/27/2022

by

The Georgia Commission for Access to Medical Cannabis has awarded its first two medical cannabis production licenses, The Current reports. The licenses to cultivate, process, and sell low-THC medical cannabis oil was awarded to Trulieve Georgia Inc. and Biological Sciences. Trulieve is building its cultivation facility in Adel and Biological Sciences is building west of Savanna in Glennville.

The announcement comes seven years after Georgia lawmakers decriminalized low-THC oil in the state. While the bill legalizing the oils was originally passed in 2015, it provided no legal way for producing the product. In 2019, the Legislature addressed the issue by creating a licensing structure and, more than a year ago, Georgia awarded six of those licenses. However, the licenses were put on hold after some applicants claimed the selection process had been unfair and arbitrary, the report says. Gov. Brian Kemp (R) ultimately set aside $150,000 from the governor’s emergency fund to hold hearings for those applicants who were not awarded licenses.

Trulieve Georgia President Lisa Pinkney told The Current that the company will begin work immediately to provide oil to patients. 

“The Georgia team is hard at work to begin operations as soon as possible to ensure those in need have access to Trulieve’s line of products. We’re also excited to share that Trulieve’s operation and its ancillary business partners are projected to create a wide range of jobs in the state as the business grows.” — Pinkney to The Current 

The company plans on initially opening five dispensaries throughout the state.

End

Michigan State Police Refuse to Elaborate On Faulty Cannabis Blood Testing

9/26/2022

by

Michigan State Police (MSP) are not offering any comment or follow-up after halting blood tests for cannabis late last month after discovering false positives for THC in the protocols. In a statement following the initial report, Shanon Banner, manager of the Public Affairs Section for MSP said the agency was “immediately halting the processing of all THC blood samples” out of an “abundance of caution” as the agency worked “to learn more” or “institute another validated method of testing to ensure accuracy.”

On August 31, the agency halted the testing following an interview with MSP Toxicology Unit Supervisor Geoffrey French by freelance reporter Eric VanDussen in which French confirmed that his department’s testing for THC levels in blood samples was unreliable and that the MSP Forensic Science Division had been using the faulty testing process for more than 20 years.

Last week, MLive asked Banner for an update, to which she responded that the “August 31 statement is still the most current information” the agency has to share.

In the statement, MSP estimated that there are more than 3,000 cases that could be impacted by faulty THC blood tests but that any drug tests that confused CBD and THC prior to March 28, 2019, are moot because hemp remained outlawed in Michigan.

“CBD, which is structurally similar to THC, was illegal in Michigan until March 28, 2019,” state police said in the statement. “Since that date, however, CBD, which is reported to have no psychoactive properties, has been legal under Michigan law.”

Arthur J. Weiss, president of the Criminal Defense Lawyers of Michigan, told MLive that he is “troubled by the way this was rolled out and the lack of transparency and information that’s been given to us.”

“There have been a number of people in the defense community for years that have indicated the crime lab should be an agency and department independent of the Michigan state police, because we’re concerned about the potential institutional bias and wondering whether this is the type of situation that reinforces that belief,” he said.

Criminal defense attorney Michael Nichols told MLive he has been “calling this to the attention of judges all over the state” for years and he doesn’t believe the state police crime lab first learned about the problem last month. He theorizes that judges and juries have ignored the problem because “they want to make their criminal justice partners… happy.”

End